Table 1.

Baseline characteristics in patients with and without obstructive sleep apnea

Item	Non-OSA (n = 35)	OSA (n = 15)	P-value
Age (years)	69.7 ± 8.9	71.8 ± 10.4	0.480
Male	27 (77)	10 (67)	0.493
Body mass index	23.6 ± 3.2	23.6 ± 3.3	0.986
Diabetes mellitus	11 (31)	4 (27)	0.736
Hypertension	23 (66)	12 (80)	0.502
Dyslipidemia	29 (83)	12 (80)	0.810
Chronic kidney disease	7 (20)	4 (27)	0.713
Current smoker	13 (37)	4 (27)	0.474
Apnea hypopnea index	7.2 ± 3.8	30.9 ± 12.6	< 0.001
Family history of coronary artery disease	4 (11)	3 (20)	0.415
History of PCI or CABG	15 (43)	5 (33)	0.529
History of myocardial infarction	11 (31)	1 (7)	0.079
History of TIA or cerebral infarction	3 (9)	0	0.545
History of peripheral artery disease	0	1 (7)	0.300
Prior statin use	11 (31)	6 (40)	0.558
Duration <3 months	0	0	–
3–12 months	3 (9)	2 (13)	0.607
≥12 months	8 (23)	4 (27)	0.942
Prior aspirin use	15 (43)	7 (47)	0.804
Prior clopidogrel use	11 (31)	2 (13)	0.294
Prior ACEI or ARB	9 (26)	6 (40)	0.333
Prior calcium channel blocker use	12 (34)	4 (27)	0.746
Prior beta blocker use	10 (29)	4 (27)	0.891
Prior eicosapentaenoic acid	4 (11)	1 (7)	0.607
Prior ezetimibe	4 (11)	0	0.302
Hemoglobin (g/dl)	13.5±1.5	13.3 ± 2.0	0.800
HbA1c (%)	6.4 ± 1.4	6.2 ± 1.1	0.662
Glucose (mg/dl)	140 ± 78	144 ± 64	0.882
LDL-C (mg/dl)	104 ± 45	107 ± 29	0.732
Triglyceride (mg/dl)	115 (86)	172 (136)	0.564
HDL-C (mg/dl)	49 ± 12	50 ± 14	0.936
LDL-C to HDL-C ratio	2.2 ± 1.1	2.3 ± 0.9	0.660
Acute coronary syndrome	18 (51)	10 (67)	0.320
ST-elevation myocardial infarction	9 (26)	6 (40)	0.333
Non ST-elevation myocardial infarction	9 (26)	4 (27)	0.944

Values are mean ± SD or number (%) of observations

PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, TIA transient ischemic attack, ACEangiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker